| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.3 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.3 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |